William Arsani
Design Therapeutics, Inc. · Director
William Arsani is listed in filings as Director at Design Therapeutics, Inc.. This profile follows SEC Form 4 activity through Aug 14, 2025, including sale activity. Recent filings connect the profile to Design Therapeutics, Inc. (DSGN). The current snapshot covers public activity from Jun 17, 2024 to Aug 14, 2025. Reported amounts are shown as $1.8M to $76.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $3M814.9k shares | SellAug 9, 2024 | $4.25 | $12.61 |